Literature DB >> 19803004

Clinical experience with ceftazidime for lower respiratory tract infections.

G De Sandre1, R I Corrocher, G B Gabrielli, I Ho.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 19803004     DOI： 10.1093/jac/8.suppl_b.307

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  1 in total

1.  A multicentre, randomized comparative study of 500 mg versus 1,000 mg ceftazidime t.d.s. for treatment on gram-negative infections.

Authors:  H Mattie; M W Kunst; H I Schievink; P L Jonker; P de Jonge
Journal:  Infection       Date:  1995 Jul-Aug       Impact factor: 3.553
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.